Socioeconomic variation and prostate specific antigen testing in the community: A United Kingdom based population study

Journal of Urology

Volumn 190, Issue 4, 2013, Pages 1207-1212

  Morgan, Rhian M ^a,b   Steele, Robert J C ^a,b   Nabi, Ghulam ^a,b   McCowan, Colin ^a,b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

mortality; prostate; prostate specific antigen; prostatic neoplasms; social class

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; GLEASON SCORE; HUMAN; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SOCIAL STATUS; TUMOR DIFFERENTIATION; UNITED KINGDOM;

GENERAL PRACTITIONER; GP; MORTALITY; PROSTATE; PROSTATE SPECIFIC ANTIGEN; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PSA; SCOTTISH INDEX OF MULTIPLE DEPRIVATION; SES; SIMD; SOCIAL CLASS; SOCIOECONOMIC STATUS;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SCOTLAND; SOCIOECONOMIC FACTORS;

EID: 84883820733     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.04.044     Document Type: Article

References (26)

1. A.W. Hsing, L. Tsao, and S.S. Devesa International trends and patterns of prostate cancer incidence and mortality Int J Cancer 85 2000 60
2. Information Services Division Scotland NHS National Services Scotland: Male Genital Organ Cancer, Prostate Cancer of the Prostate: ICD-10 C61, Annual Incidence. Available at http://www.isdscotland.org/Health-Topics/Cancer/Cancer- Statistics/Male-Genital-Organs/#prostate. Accessed December 18, 2010.
3. Information Services Division Scotland NHS National Services Scotland: Cancer in Scotland (2010). Available at http://www.isdscotland.org/Health- Topics/Cancer/Publications/2011-10-25/Cancer-in-Scotland-summary-m.pdf. Accessed December 18, 2011.
4. J. Anderson Does PSA testing influence the natural history of prostate cancer? Eur Urol, suppl. 1 2002 3
5. G. Bartsch, W. Horninger, and H. Klocker Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol Austria Urol 58 2001 417
6. D.H. Brewster, L.A. Fraser, and V. Harris Rising incidence of prostate cancer in Scotland: increased risk or increased detection? BJU Int 85 2000 463
7. Information Services Division Scotland NHS National Services Scotland: Cancer Mortality in Scotland (2010). Available at http://www.isdscotland.org/ Health-Topics/Cancer/Publications/2011-10-25/2011-10-25-CancerMortality-Report. pdf?64919680357. Accessed December 18, 2011.
8. J. Melia, S. Moss, and L. Johns Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study BJU Int 94 2004 51
9. L. Liu, W. Cozen, and L. Bernstein Changing relationship between socioeconomic status and prostate cancer incidence J Natl Cancer Inst 93 2001 705
10. T.I.L. Nilsen, R. Johnsen, and L.J. Vatten Socio-economic and lifestyle factors associated with the risk of prostate cancer Br J Cancer 82 2000 1358
11. E. Rapiti, G. Fioretta, and R. Schaffar Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis Cancer 115 2009 5556
12. C.T. Schrijvers, and J.P. Mackenbach Cancer patient survival by socioeconomic status in seven countries: a review for six common cancer sites J Epidemiol Commun Health 48 1994 441
13. E. Banks, V. Beral, and R. Cameron Comparison of various characteristics of women who do and do not attend for breast cancer screening Breast Cancer Res 4 2002 R1
14. B.L. Jackson, K. Hope, and C.L. Jackson PSA testing and its relationship with social deprivation Br J Med Surg Urol 5 2012 74
15. Information Services Division Scotland NHS National Services Scotland: Male Genital Organ Cancer, Prostate Cancer of the Prostate: ICD-10 C61, Annual Mortality. Available at http://www.isdscotland.org/Health-Topics/Cancer/Cancer- Statistics/Male-Genital-Organs/#prostate. Accessed December 18, 2010.
16. University of Dundee: Health Informatics Centre, School of Medicine. Available at http://medicine.dundee.ac.uk/health-informatics-centre. Accessed December 18, 2012.
17. The Scottish Government: Scottish Index of Multiple Deprivation. Available at http://www.scotland.gov.uk/Topics/Statistics/SIMD. Accessed December 18, 2012.
18. D.C. Burford, M. Kirby, and J. Austoker Prostate cancer risk management programme information for primary care: PSA testing in asymptomatic men. Evidence document NHS Cancer Screening Programmes 2010 Public Health England Sheffield, United Kingdom
19. F.D. Gilliland, D.F. Gleason, and W.C. Hunt Trends in Gleason score for prostate cancer diagnosed between 1983 and 1993 J Urol 165 2001 846
20. R.M. Hoffman Screening for prostate cancer N Engl J Med 365 2011 2013
21. B.F. Hankey, E.J. Feuer, and L.X. Clegg Cancer surveillance series: interpreting trends in prostate cancer - part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates J Natl Cancer Inst 91 1999 1017
22. J.A. Winterich, J.G. Grzywacz, and S.A. Quandt Men's knowledge and beliefs about prostate cancer: education, race, and screening status Ethnicity Dis 19 2009 199
23. Hilton S: Assessment of the wider health needs of black and minority ethnic groups in Tayside. In: Revised Race Equality Scheme and Action Plan 2008-2011. NHS Tayside. Available at http://www.nhstayside.scot.nhs.uk/equality/ NHS%20Tayside%20Race%20Equality%20Scheme%20-%202008-2011.pdf. Accessed December 18, 2008.
24. I. Cheng, J.S. Witte, and L.A. McClure Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California Cancer Causes Control 20 2009 1431
25. D. Ilic, D. O'Connor, and S. Green Screening for prostate cancer: an updated Cochrane systematic review BJU Int 107 2011 882
26. D.E. Neal, J.L. Donovan, and R.M. Martin Screening for prostate cancer remains controversial Lancet 374 2009 1482